the kind of transcutaneous disruption of adipocytes seen with the Liposonix system. ‘The only comparable therapy would be cryolipolysis … which is limited to treating fewer body areas, won’t create tightening, and has no chance of improving cellulite,’ he explained. ‘Our research with the Liposonix Model 1 system demonstrated an average non-invasive circumference reduction of approximately 4.8 cm with concurrent skin tightening. With the new device the treatment is even more comfortable for the patient than before, and easier to perform due to the new software and both the size and maneuverability of the new handpiece. We’re seeing initial results with the Liposonix Model 2 system that are at least similar to what we previously achieved.’ ‘Although I was initially delighted
by its reduced size, elegant design, and appearance,’ said practising dermatologist Thomas Proebstle, (Mannheim, Germany), ‘the real advantages of the Liposonix Model 2 system are the easier replacement of the transducer tips, and dramatically improved software that provides the user with additional treatment spot shapes beyond a simple square. This is a great step toward tailoring [the] treatment to each individual body region.’ ‘The HIFU modality itself provides the impressive tissue heating capabilities with a single treatment when compared with the often disappointing results seen with multi-treatment, non-heating, cavitational systems that are in widespread use,’ Prof Dr Proebstle continued. ‘Patients love that the Liposonix treatment is easy and
“The Liposonix system is not
comparable to surgery but the results are visible, with notable
tightening, which is a key component of the overall result.
”
relatively comfortable, with little preparation other than pictures, measurements, and marking. The total in-office time can be less than 2 hours.’
The minimal and reportedly
tolerable discomfort associated with the treatment — without anaesthesia — is accompanied by a complete lack of downtime, according to Dr Mazer. ‘Patients may resume normal activity immediately after the procedure,’ he said.
Optimisation of results Although the Liposonix system is designed for non-invasive body contouring, it is not an alternative to surgery. ‘This addresses the obvious trend in the industry toward less invasive, less risk, less discomfort, and less downtime, but with measurable results patients can see for themselves,’ said Dr Mazer. ‘The Liposonix system is not comparable to surgery but the results are visible, with notable tightening, which is a key component of the overall result. With proper management of expectations, patient satisfaction is very high.’ While some visible results may seem to appear almost immediately, the full outcome manifests within approximately 8–12 weeks. ‘The ideal candidate,’ stated Dr
Rakus, ‘should have a BMI under 30, be otherwise fit and healthy, and pursue a positive, healthy lifestyle in general. Ultimately [the Liposonix treatment] is best for patients with stubborn pockets of fat. The patient needs to be aware of other skin tightening modalities such as Thermage CPT, which in combination could be used to optimise the results pre- or post-treatment.’
Conclusions Dr Rakus is a strong believer in the value and capabilities of the Liposonix system, as well as Solta Medical. ‘This device is superior to market alternatives and is a must- have for aesthetic clinics featuring non-invasive capabilities that wish to offer their patients the best options available,’ she said. ‘No other device can offer the combination of efficacy and flexibility unique to the Liposonix Model 2 system. Also, we can trust Solta Medical’s reputation to stick with and support this technology as well as continue to develop it.’
For further information contact:
info@solta.com +31 (0) 20-653-7060
AMWC stand number: E26
prime-journal.com | March 2012 ❚
79
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112